NCT05910411

Brief Summary

The appearance of revascularization edema of the lower limb is a frequent complication in peripheral vascular surgery. It can lead to a delay in healing and even to trophic disorders. The prevention and treatment of this complication have so far been limited to postural measures (elevation of the limbs), in the absence of other recommendations and given the contraindication of elastic compression. Inelastic compression is another mode of compression sometimes used in the treatment of lymphedema. It exerts a stable continuous pressure regardless of the patient's position. The investigator's aim is to demonstrate that compression with inelastic bands, applied under good conditions, does not have a major effect on distal arterial vascularization in arterial patients who have undergone revascularization by supra-articular bypass or endovascular treatment of the lower limb.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 2, 2023

Completed
16 days until next milestone

First Posted

Study publicly available on registry

June 18, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

December 11, 2023

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 11, 2026

Completed
Last Updated

March 19, 2025

Status Verified

March 1, 2025

Enrollment Period

2.5 years

First QC Date

June 2, 2023

Last Update Submit

March 18, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Evaluating the safety of inelastic compression

    no skin complications OR a drop in toe blood pressure and/or transcutaneous oxygen pressure (TCPO2) and/or TMS of 20% before and after placement of the compression

    day 5

Secondary Outcomes (2)

  • threshold of cPSI below which the application of inelastic compression results in altered arterial flow.

    day 5

  • toe pressure below which the application of inelastic compression results in altered arterial flow.

    day 5

Study Arms (1)

Inelastic compression

EXPERIMENTAL

Inelastic compression used in the treatment of lymphedema

Device: Inelastic compression

Interventions

Inelastic compression used in the treatment of lymphedema

Inelastic compression

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients over 18 years of age
  • arteriopathic patients requiring femoropopliteal revascularization by bypass surgery who have been revascularized
  • signature of an informed consent
  • person affiliated or beneficiary of a social security plan

You may not qualify if:

  • arterial bypasses under the leg or distal joints
  • critical ischemia
  • patients operated on for acute ischemia
  • pregnant or breast-feeding women
  • severe cardiac insufficiency
  • \) severe peripheral neuropathy 6) allergies to the components of the tapes 7) persons deprived of liberty by judicial or administrative decision 8) persons under legal protection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Nice

Nice, France, 06000, France

RECRUITING

MeSH Terms

Conditions

Lymphedema

Condition Hierarchy (Ancestors)

Lymphatic DiseasesHemic and Lymphatic Diseases

Study Officials

  • PASCAL GIORDANA

    Centre Hospitalier Universitaire de Nice

    PRINCIPAL INVESTIGATOR

Central Study Contacts

PASCAL GIORDANA

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 2, 2023

First Posted

June 18, 2023

Study Start

December 11, 2023

Primary Completion

June 1, 2026

Study Completion

June 11, 2026

Last Updated

March 19, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations